Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension

Hypertension

Volumn 34, Issue 1, 1999, Pages 96-101

  Wang, Jun Ling ^a   Cheng, Hui Fang ^a   Harris, Raymond C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclooxygenase; Hypertension, renal; Kidney; Macula densa; Renin

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; RENIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA COARCTATION; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; KIDNEY SIZE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION;

EID: 0032793945     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.1.96     Document Type: Article

References (38)

1. Hackenthal E, Paul M, Ganten D, Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol Rev. 1990;70: 1067-1116.
2. Schnermann J. Juxtaglomerular cell complex in the regulation of renal salt excretion. Am J Physiol. 1998;274:R263-R279.
3. Schricker K, Hamann M, Kurtz A. Prostaglandins are involved in the stimulation of renin gene expression in 2 kidney-1 clip rats. Pflugers Arch. 1995;430:188-194.
4. Schricker K, Hamann M, Kaissling B, Kurtz A. Renal autacoids are involved in the stimulation of renin gene expression by low perfusion pressure. Kidney Int. 1994;46:1330-1336.
5. Jackson EK. Oates JA, Branch RA. Indomethacin decreases arterial blood pressure and plasma renin activity in rats with aortic ligation. Circ Res. 1981;49:180-185.
6. Imanishi M, Kawamura M, Akabane S, Matsushima Y, Kuramochi M, Ito K, Ohta M, Kimura J, Takamiya M, Omae T. Aspirin lowers blood pressure in patients with renovascular hypertension. Hypertension. 1989; 14:461-468.
7. Schricker K, Holmer S, Kramer BK, Riegger G, Kurtz A. Control of renin gene expression in 2 kidney-1 clip rats. Kidney Int. 1994;46:1539-1541.
8. Schricker K, Hamann M, Kaissling B, Kurtz A. Role of the macula densa in the control of renal renin gene expression in two-kidney/one-clip rats. Pflugers Arch. 1994;427:42-46.
9. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Ann Rev Biochem. 1986;55:69-102.
10. Fletcher BS, Kujubu DA, Perrin DM, Herschman HR. Structure of the mitogen-inducible TIS 10 gene and demonstration that the TIS 10-encoded protein is a functional prostaglandin G/H synthase. J Biol Chem. 1992;267:4338-4344.
11. O'Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci U S A. 1992;89:4888-4892.
12. Smith WL, Bell TG. Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex. Am J Physiol. 1978;235: F451-F457.
13. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest. 1994;94:2504-2510.
14. Jensen BL, Kurtz A. Differential regulation of renal cyclooxygenase mRNA by dietary salt intake. Kidney Int. 1997;52:1242-1249.
15. Yang T, Singh I, Pham H, Sun D, Smart A, Schnermann JB, Briggs JP. Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol. 1998;274:F481-F489.
16. Cheng HF, Wang JL, Zhang MZ, Miyazaki Y, Ichikawa I, McKanna JA, Harris RC. Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest. 1999;103:953-961.
17. Harding P, Sigmon DH, Alfie ME, Huang PL, Fishman MC, Beierwaltes WH, Carretero OA. Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension. 1997;29:297-302.
18. Hartner A, Goppelt-Struebe M, Hilgers KF. Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension. Hypertension. 1998;31:201-205.
19. Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM, Rogers RS, Rogier DJ, Yu S, Anderson GD, Burton EG, Cogburn JN, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Veenhuizen AW, Zhang YY, Isakson PC. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J Med Chem. 1997;40:1347-1365.
20. Lin L, Mistry M, Stier C, Nasjletti A. Role of prostanoids in renin-dependent and renin-independent hypertension. Hypertension. 1991;17:517-525.
21. Santos CM, Pontieri V, Neto ML, Michelini LC. Losartan improves baroreflex control of heart rate of coarcted hypertensive rats. Am J Physiol. 1995;269:H812-H818.
22. Anderson S, Jung FF, Ingelfinger JR. Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol. 1993;265(pt 2):F477-F486.
23. Wang J-L, Cheng H-F, Zhang M-Z, McKanna JA, Harris RC. Selective increase of cyclooxygenase-2 expression in a model of renal ablation. Am J Physiol. 1998;275:F613-F622.
24. Burnham CE, Hawelu-Johnson CL, Frank BM, Lynch KR. Molecular cloning of rat renin cDNA and its gene. Proc Natl Acad Sci U S A. 1987;84:5605-5609.
25. Stoff JS. Prostaglandins and hypertension. Am J Med. 1986;80:56-61.
26. Smith MC, Dunn MJ. The role of prostaglandins in human hypertension. Am Kidney Dis. 1985;5:A32-A39.
27. Rocchini AP, Behrendt D. Polyuria, polydypsia and hypertension produced by a six-day intravenous infusion of prostaglandin E1 in the conscious dog. Hypertension. 1984;6:431-436.
28. Hockel GM, Cowley AW Jr. Role of the renin-angiotensin system in prostaglandin E2-induced hypertension. Hypertension. 1980;2: 529-537.
29. Hockel GM, Cowley AW Jr. Effect of chronic intrarenal prostaglandin E2 infusion and angiotensin II blockade on arterial pressure in the dog. Adv Prostaglandin Thromboxane Res. 1980;7:1061-1065.
30. Imanishi M, Akabane S, Takamiya M, Kawamura M, Matsushima Y, Kuramochi M, Omae T. Critical degree of renal arterial stenosis that causes hypertension in dogs. Angiology. 1992;4:833-842.
31. Harris RC. The macula densa: recent developments. J Hypertens. 1996; 14:815-822.
32. Stahl R, Dienemann H, Besserer K, Kneissler U, Helmchen U. Effect of indomethacin on blood pressure in rats with renovascular hypertension: dependence on plasma renin activity. Klin Wochenschr. 1981;59: 245-246.
33. Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD, Smith WL. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 1994;271:927-934.
34. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 1993;268: 6610-6614.
35. Komhoff M, Grone HJ, Klein T, Seyberth HW, Nusing RM. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol. 1997;272(pt 2):F460-F468.
36. Brunel P, Hornych A, Guyene TT, Sioufi A, Turri M, Menard J. Renal and endocrine effects of flosulide, after single and repeated administration to healthy volunteers. Eur J Clin Pharmacol. 1995;49:193-201.
37. Stichtenoth DO, Wagner B, Frolich JC. Effect of selective inhibition of the inducible cyclooxygenase on renin release in healthy volunteers. J Investig Med. 1998;46:290-296.
38. Lorenz JN, Weihprecht H, Schnermann J, Skott O, Briggs JP. Renin release from isolated juxtaglomerular apparatus depends on macula densa chloride transport. Am J Physiol. 1991;260(pt 2):F486-F493.